ctrl K

AI Score

Unlock

Janux Therapeutics Inc. (JANX)

AI Score

Unlock

29.04

-0.74 (-2.48%)

At close: Mar 28, 2025, 3:59 PM

30.26

4.22%

After-hours: Mar 28, 2025, 06:17 PM EDT

Janux Therapeutics Income Statement

Table Mode

Year	FY24	FY23	FY22	FY21	FY20	FY19
Revenue	10.59M	8.08M	8.61M	3.64M	n/a	n/a
Cost of Revenue	n/a	1.96M	841K	113K	13K	6K
Gross Profit	10.59M	6.13M	7.77M	3.52M	-13K	-6K
Operating Income	-98.85M	-72.98M	-67.09M	-32.93M	-4.84M	-3.77M
Interest Income	29.85M	14.69M	4.03M	257K	206K	233K
Pretax Income	-68.99M	-58.29M	-63.06M	-32.67M	-6.78M	-4M
Net Income	-68.99M	-58.29M	-54.15M	-32.56M	-5.25M	-4.24M
Selling & General & Admin	41.05M	26.14M	22.26M	10.33M	1.8M	772K
Research & Development	68.39M	54.92M	53.44M	26.24M	3.04M	3M
Other Expenses	n/a	n/a	4.03M	257K	-1.74M	n/a
Operating Expenses	109.44M	81.06M	75.7M	36.57M	4.84M	3.77M
Interest Expense	n/a	n/a	4.03M	n/a	206K	233K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	109.44M	81.06M	75.7M	36.57M	4.84M	3.77M
Income Tax	n/a	n/a	-8.9M	-113K	-1.53M	233K
Shares Outstanding (Basic)	53.75M	44.02M	41.47M	41.24M	41.61M	41.61M
Shares Outstanding (Diluted)	53.75M	44.02M	41.47M	41.24M	41.61M	41.61M
EPS (Basic)	-1.28	-1.32	-1.31	-0.79	-0.13	-0.1
EPS (Diluted)	-1.28	-1.32	-1.31	-0.79	-0.13	-0.1
EBITDA	-98.85M	-71.02M	-66.25M	-32.82M	-4.83M	-3.77M
Depreciation & Amortization	n/a	1.96M	841K	113K	13K	6K